These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
509 related items for PubMed ID: 30203264
1. Hypophosphatasia: From Diagnosis to Treatment. Simon S, Resch H, Klaushofer K, Roschger P, Zwerina J, Kocijan R. Curr Rheumatol Rep; 2018 Sep 10; 20(11):69. PubMed ID: 30203264 [Abstract] [Full Text] [Related]
2. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia. Scott LJ. Drugs; 2016 Feb 10; 76(2):255-62. PubMed ID: 26744272 [Abstract] [Full Text] [Related]
3. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Mol Genet Metab; 2017 Sep 10; 122(1-2):4-17. PubMed ID: 28888853 [Abstract] [Full Text] [Related]
4. Asfotase alfa: enzyme replacement for the treatment of bone disease in hypophosphatasia. Hofmann C, Seefried L, Jakob F. Drugs Today (Barc); 2016 May 10; 52(5):271-85. PubMed ID: 27376160 [Abstract] [Full Text] [Related]
5. Asfotase alfa therapy for children with hypophosphatasia. Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, Mack KE, Hamilton K, Kagan K, Fujita KP, Thompson DD, Moseley S, Odrljin T, Rockman-Greenberg C. JCI Insight; 2016 Jun 16; 1(9):e85971. PubMed ID: 27699270 [Abstract] [Full Text] [Related]
11. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia. Bowden SA, Adler BH. Osteoporos Int; 2018 Feb 16; 29(2):511-515. PubMed ID: 29046930 [Abstract] [Full Text] [Related]
12. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy. Bowden SA, Foster BL. Drug Des Devel Ther; 2018 Feb 16; 12():3147-3161. PubMed ID: 30288020 [Abstract] [Full Text] [Related]
15. Enzyme-replacement therapy in perinatal hypophosphatasia: Case report and review of the literature. Rougier H, Desrumaux A, Bouchon N, Wroblewski I, Pin I, Nugues F, Mornet E, Baujat G. Arch Pediatr; 2018 Oct 16; 25(7):442-447. PubMed ID: 30249491 [Abstract] [Full Text] [Related]
16. Efficacy and safety of asfotase alfa in patients with hypophosphatasia: A systematic review. Shirinezhad A, Esmaeili S, Azarboo A, Tavakoli Y, Hoveidaei AH, Zareshahi N, Ghaseminejad-Raeini A. Bone; 2024 Nov 16; 188():117219. PubMed ID: 39089608 [Abstract] [Full Text] [Related]
17. Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth. Okazaki Y, Kitajima H, Mochizuki N, Kitaoka T, Michigami T, Ozono K. Eur J Pediatr; 2016 Mar 16; 175(3):433-7. PubMed ID: 26459154 [Abstract] [Full Text] [Related]
18. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia. Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, Thompson DD, Bishop N, Hofmann C. J Clin Endocrinol Metab; 2016 Jan 16; 101(1):334-42. PubMed ID: 26529632 [Abstract] [Full Text] [Related]